Director, Chief Executive Officer · Terns Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$282K
Shares
7,521
Price
$37.53
Executed
Jan 15, 2026
Disclosed
Jan 16, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 15 executedJan 16, 2026 disclosed
TERN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Burroughs Amy L. filed this Form 4 reporting a open-market sale of TERN on Jan 15, 2026. It became public on Jan 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Burroughs Amy L.cik:0001872564
Issuer
Terns Pharmaceuticals, Inc.cik:0001831363
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for TERN is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
